XtalPi AI Advances Viva-Thera HIV Drug Discovery Program
Boston, Massachusetts, U.S., September 22, 2026 XtalPi has announced that its artificial intelligence-enabled drug discovery platform helped Viva-Thera Technologies...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Boston, Massachusetts, U.S., September 22, 2026 XtalPi has announced that its artificial intelligence-enabled drug discovery platform helped Viva-Thera Technologies...
Branchburg, New Jersey, U.S., September 22, 2026 ClorDiSys Solutions Inc. has announced the publication of a peer-reviewed study in...
Tampa, Florida, U.S., September 22, 2026 Tampa General Hospital has become the first academic health system in the Southeast...
